The same but different: Autologous hematopoietic stem cell transplantation for patients with lymphoma and HIV infection

Bone Marrow Transplantation

Volumn 44, Issue 1, 2009, Pages 1-5

  Ambinder, R F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ATOVAQUONE; BLEOMYCIN; BUSULFAN; CARMUSTINE; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DAPSONE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUCONAZOLE; FOLINIC ACID; GANCICLOVIR; MELPHALAN; METHOTREXATE; PREDNISOLONE; RITUXIMAB; VALACICLOVIR; VALGANCICLOVIR; VINCRISTINE; ZIDOVUDINE;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG CONTRAINDICATION; HERPES VIRUS INFECTION; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOMA; MORTALITY; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PNEUMOCYSTOSIS; PRIORITY JOURNAL; REVIEW; VEIN OCCLUSION; VIRUS LOAD;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; HUMANS; LYMPHOMA; TRANSPLANTATION, AUTOLOGOUS;

EID: 67651089710     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.105     Document Type: Review

References (26)

1. Holland HK, Saral R, Rossi JJ, Donnenberg AD, Burns WH, Beschorner WE et al. Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma. Ann Intern Med 1989; 111: 973-981.
2. Persad GC, Little RF, Grady C. Including persons with HIV infection in cancer clinical trials. J Clin Oncol 2008; 26: 1027-1032.
3. Pomerantz RJ, Horn DL. Twenty years of therapy for HIV-1 infection. Nat Med 2003; 9: 867-873.
4. Rothenberg R, Woelfel M, Stoneburner R, Milberg J, Parker R, Truman B. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med 1987; 317: 1297-1302.
5. Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, Wood E et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS 2007; 21: 685.
6. Shen L, Peterson S, Sedaghat AR, McMahon MA, Callender M, Zhang H et al. Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs. Nat Med 2008; 14: 762-766.
7. Engels EA, Goedert JJ. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: Past, present, and future. J Natl Cancer Inst 2005; 97: 407-409.
8. Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006; 108: 3786-3791.
9. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992; 80: 8-20.
10. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997; 336: 1641-1648.
11. Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B et al. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 2001; 19: 2171-2178.
12. Sparano JA, Lee S, Chen MG, Nazeer T, Einzig A, Ambinder RF et al. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: An Eastern Cooperative Oncology Group Trial (E1494). J Clin Oncol 2004; 22: 1491-1500.
13. Spina M, Jaeger U, Sparano JA, Talamini R, Simonelli C, Michieli M et al. Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: Pooled results from 3 phase 2 trials. Blood 2005; 105: 1891-1897.
14. Boue F, Gabarre J, Gisselbrecht C, Reynes J, Cheret A, Bonnet F et al Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. J Clin Oncol 2006; 24 4123-4128.
15. Little RF, Pittaluga S, Grant N, Steinberg SM, Kavlick MF, Mitsuya H et al. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: Impact of antiretroviral therapy suspension and tumor biology. Blood 2003; 101: 4653-4659.
16. Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A et al. Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS Malignancies Consortium Trial 010. Blood 2005; 106: 1538-1543.
17. Levine AM, Lee J, Kaplan L, Liebes LF, Sparano JA. Efficacy and toxicity of concurrent rituximab plus infusional EPOCH in HIV-associated lymphoma: AIDS Malignancy Consortium Trial 034. J Clin Oncol 2008; 26(Suppl): 8527.
18. Re A, Cattaneo C, Michieli M, Casari S, Spina M, Rupolo M et al. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 2003; 21: 4423-4427.
19. Gabarre J, Marcelin AG, Azar N, Choquet S, Levy V, Levy Y et al. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Haematologica 2004; 89: 1100-1108.
20. Krishnan A, Molina A, Zaia J, Smith D, Vasquez D, Kogut N et al. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 2005; 105: 874-878.
21. Serrano D, Carrion R, Balsalobre P, Miralles P, Berenguer J, Buno I et al. HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Exp Hematol 2005; 33: 487-494.
22. Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ et al. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium Study 020. Biol Blood Marrow Transplant 2008; 14: 59-66.
23. Nagamura F, Takahashi T, Takeuchi M, Iseki T, Ooi J, Tomonari A et al Effect of cyclophosphamide on serum cyclosporine levels at the conditioning of hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 32: 1051-1058.
24. Robertson SM, Penzak SR, Pau A. Drug interactions in the management of HIV infection: An update. Expert Opin Pharmacother 2007; 8: 2947-2963.
25. Taylor S, Boffito M, Khoo S, Smit E, Back D. Stopping antiretroviral therapy. AIDS 2007; 21: 1673-1682.
26. Flexner C. HIV drug development: The next 25 years. Nat Rev 2007; 6: 959-966.